Achieving comprehensive lipid profiling with a CCS, retention time and MS/MS library
Posters | 2021 | Waters | ASMSInstrumentation
Comprehensive lipid profiling is essential for understanding complex biological processes, disease biomarkers, and metabolic regulation. The combination of ion mobility separation, retention time measurement, and MS/MS spectral libraries enhances confidence in lipid identification and quantification, addressing challenges in reproducibility and cross-laboratory comparability.
This study aimed to develop and validate a high-coverage lipid database incorporating experimental and predicted collisional cross section (CCS) values, retention times, and MS/MS spectra. A pilot study on metabolic syndrome samples was included to demonstrate the utility of the database in differentiating healthy, obese, and diabetic cohorts.
Further expansion of experimentally derived CCS databases and incorporation of machine-learning predictions will improve coverage and accuracy. Integration with real-time data analytics and cloud-based libraries will facilitate multi-site studies. Emerging applications include personalized medicine, environmental lipidomics, and real-time monitoring of bioprocesses.
The developed lipid CCS, retention time, and MS/MS library provides a robust resource for comprehensive lipid profiling. Validation against authentic standards and application to metabolic syndrome samples demonstrate its reliability and practicality for diverse lipidomics studies.
Ion Mobility, LC/TOF, LC/HRMS, LC/MS, LC/MS/MS
IndustriesLipidomics
ManufacturerWaters
Summary
Importance of the topic
Comprehensive lipid profiling is essential for understanding complex biological processes, disease biomarkers, and metabolic regulation. The combination of ion mobility separation, retention time measurement, and MS/MS spectral libraries enhances confidence in lipid identification and quantification, addressing challenges in reproducibility and cross-laboratory comparability.
Objectives and study overview
This study aimed to develop and validate a high-coverage lipid database incorporating experimental and predicted collisional cross section (CCS) values, retention times, and MS/MS spectra. A pilot study on metabolic syndrome samples was included to demonstrate the utility of the database in differentiating healthy, obese, and diabetic cohorts.
Methodology and instrumentation
- CCS prediction model: Broeckling et al. TWCCSN2 model validated with over 100 authentic lipid standards (individual and premixed).
- Chromatography: ACQUITY Premier UPLC I-Class coupled to CSH C18 column (2.1 x 100 mm, 1.7 µm) using a 12-minute reversed-phase gradient.
- Ion mobility-MS: SYNAPT XS instrument with HDMSe acquisition and Nature Protocol Triwave settings.
- Data acquisition: Positive and negative electrospray ionization modes, triplicate injections at three concentration levels.
- Data processing: UNIFI and Progenesis QI software for CCS calibration, retention time alignment, MS/MS matching, and statistical analysis via MetaboAnalyst.
Key results and discussion
- Predicted vs. experimental CCS values showed over 96% agreement within ±5% error in both ionization modes, confirming model accuracy.
- The curated library contains >3 200 lipid species across major classes with assigned retention times and MS/MS spectra for enhanced specificity.
- Biological extracts (brain, heart, liver, plasma) verified the applicability of the database to complex matrices, confirming lipid chain distributions.
- Pilot metabolic syndrome study: PLS-DA models distinguished healthy, obese, and diabetic groups with tight QC clustering. Top features included specific phospholipid and triacylglycerol species identified by combined CCS and fragmentation scoring.
Benefits and practical applications
- Increased confidence in lipid identifications through orthogonal CCS, retention time, and MS/MS criteria.
- Reduced false positives and improved reproducibility across laboratories and instrument platforms.
- High-throughput workflow suitable for large sample cohorts in clinical and industrial lipidomics.
- Flexible informatics integration with UNIFI, Progenesis QI, and MetaboAnalyst for rapid data processing and visualization.
Future trends and potential applications
Further expansion of experimentally derived CCS databases and incorporation of machine-learning predictions will improve coverage and accuracy. Integration with real-time data analytics and cloud-based libraries will facilitate multi-site studies. Emerging applications include personalized medicine, environmental lipidomics, and real-time monitoring of bioprocesses.
Conclusion
The developed lipid CCS, retention time, and MS/MS library provides a robust resource for comprehensive lipid profiling. Validation against authentic standards and application to metabolic syndrome samples demonstrate its reliability and practicality for diverse lipidomics studies.
Reference
- Paglia G, Smith AJ, Astarita G. Ion mobility mass spectrometry in the omics era: challenges and opportunities for metabolomics and lipidomics. Mass Spectrom Rev. doi:10.1002/mas.21686.
- Paglia G, Astarita G. Metabolomics and lipidomics using traveling-wave ion mobility mass spectrometry. Nat Protoc. 2017;12:797–813.
- Broeckling CD et al. Application of predicted collisional cross section to metabolome databases to probabilistically describe the current and future ion mobility mass spectrometry. J Am Soc Mass Spectrom. 2021;doi:10.1021/jasms.0c00375.
- Xia J, Psychogios N, Young N, Wishart DS. MetaboAnalyst: a web server for metabolomic data analysis and interpretation. Nucleic Acids Res. 2009;37:W652–660.
Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.
Similar PDF
Achieving Comprehensive Lipid Profiling with a CCS, Retention Time, and MS/MS Library
2021|Waters|Applications
Application Note Achieving Comprehensive Lipid Profiling with a CCS, Retention Time, and MS/MS Library Nyasha Munjoma, Sarah Lennon, Jeff Goshawk, Hans Vissers, Giorgis Isaac, Graham Mullard, Steven Lai, Lee A. Gethings, Robert S. Plumb Waters Corporation For research use only.…
Key words
ccs, ccsprogenesis, progenesisunifi, unifiinformatics, informaticslibrary, librarypredicted, predictedcredible, crediblelipid, lipidflexibility, flexibilitydatabase, databasehdmse, hdmsecomprehensive, comprehensivesynapt, synaptvalidating, validatingvalues
APPLICATION NOTEBOOK - UNTARGETED METABOLOMICS AND LIPIDOMICS
2016|Waters|Guides
[ APPLICATION NOTEBOOK ] UNTARGETED METABOLOMICS AND LIPIDOMICS 1 1 This notebook is an excerpt from the larger Waters’ Application Notebook on Metabolomics and Lipidomics #720005245EN TABLE OF CONTENTS 3 Introduction 4 Development of a Metabolomic Assay for the Analysis…
Key words
neg, negpos, posacid, acidaminoacid, aminoaciduplc, uplcbasmati, basmatitransomics, transomicsbasic, basiclipids, lipidsmobility, mobilitylipid, lipidinformatics, informaticsprogenesis, progenesisnucleoside, nucleosidemetabolomics
Metabolomics: LIPIDOMIC AND DESI IMAGING STUDY OF MOUSE LIVER DOSED WITH A TYROSINE KINASE INHIBITING DRUG
2022|Waters|Posters
LIPIDOMIC AND DESI IMAGING STUDY OF MOUSE LIVER DOSED WITH A TYROSINE KINASE INHIBITING DRUG Nyasha Munjoma 1 , Giorgis Isaac 2 , Mark Towers 1 , Emmanuelle Claude 1 , Ian D Wilson 3 , Lee A. Gethings 1…
Key words
desi, desiuntargeted, untargetedimaging, imaginggefitinib, gefitiniblipidomics, lipidomicsccs, ccstissue, tissuelipid, lipidkinase, kinasegefitnib, gefitnibpremier, premiertreated, treatedstatistical, statisticalomics, omicstyrosine
Rapid Microbore Metabolic Profiling (RAMMP) with Ion Mobility for the Lipidomic Investigation of Plasma from Breast Cancer Patients
2018|Waters|Applications
[ APPLICATION NOTE ] Rapid Microbore Metabolic Profiling (RAMMP) with Ion Mobility for the Lipidomic Investigation of Plasma from Breast Cancer Patients Adam M. King,1 Lee A. Gethings,1 and Robert S. Plumb 2 1 Waters Corporation, Wilmslow, UK; 2 Waters…
Key words
rammp, rammplipidomic, lipidomicmicrobore, microboremetabolic, metabolicprofiling, profilinglipid, lipidbreast, breastmobility, mobilityinvestigation, investigationpatients, patientscancer, cancerrapid, rapidplasma, plasmauplc, uplcprogenesis